OptimizeRx (OPRX) Short-term Investments (2022 - 2023)
OptimizeRx (OPRX) reported Short-term Investments of $53.6 million for Q3 2023, up 43.11% on a YoY basis from $37.5 million in Q3 2022, and up 1.3% sequentially from $52.9 million in Q2 2023.
OptimizeRx (OPRX) Short-term Investments (2022 - 2023) Analysis & Trends
OptimizeRx (OPRX) has 2 years of Short-term Investments data on file, last reported at $53.6 million in Q3 2023.
- For the quarter ending Q3 2023, Short-term Investments rose 43.11% year-over-year to $53.6 million; the trailing twelve-month figure through Sep 2023 stood at $53.6 million (up 43.11% YoY), and the FY2022 full-year result was $55.9 million, changed N/A from the prior year.
- Short-term Investments advanced to $53.6 million in Q3 2023, from $52.9 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $57.3 million in Q1 2023 to a low of $37.5 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - |
| 10 | OptimizeRx | 127.35 Mn | 107.18 Mn | 14.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 53.62 Mn |
| Jun 30, 2023 | 52.93 Mn |
| Mar 31, 2023 | 57.26 Mn |
| Dec 31, 2022 | 55.93 Mn |
| Sep 30, 2022 | 37.47 Mn |